Is OPTAx™ useful for monitoring the effect of stimulants on hyperactivity and inattention?
- First Online:
The purpose of this study was to investigate whether OPTAx, an objective measurement of hyperactivity, impulsivity and inattention can be used to measure the positive clinical effect of stimulants found in children with hyperkinetic disorder (HKD) or attention deficit disorder without hyperactivity.
A total of 22 boys and one girl, with ages ranging between 7–12 years, diagnosed with HKD or attention deficit disorder without hyperactivity and receiving treatment with stimulants were tested with OPTAx, with and without stimulants. The main parameters investigated were: displacement, area, accuracy, variability, errors of commission and errors of omission.
OPTAx showed a significant improvement on all parameters during stimulant treatment compared with no treatment. The improvement measured by OPTAx was supported by clinical assessment, which found that 95% of the children improved much or very much on the Clinical Global Assessment Scale during stimulant treatment.
The objective parameters of the OPTAx reflected the clinical improvement found in children with HKD or attention deficit disorder without hyperactivity during stimulant treatment. This suggests a greater role for objective measurements such as OPTAx in daily clinical practise.
Keywordsinattention stimulants OPTAx
- 1.Washington D (1994) American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. (DSM-IV)Google Scholar
- 2.World Health Organization Geneva (1993) The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic criteria for research. World health organization, GenevaGoogle Scholar
- 19.Heiser P, Frey J, Smidt J, Sommerlad C, Wehmeier PM, Hebebrand J, Remschmidt H (2004) Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate. Eur Child Adolesc Psychiatry 13:100–104PubMedCrossRefGoogle Scholar
- 22.Guy W (2005) ECDEU Assessment Manual for Psychopharmacology—Revised (DHEW Publ No ADM 76–338). Rockville, MD. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976, pp 218–222Google Scholar
- 23.StataCorp. 2003. Stata Statistical Software: Release 8.0. 2005. College Station, TX: Stata Corporation. Ref Type: Computer ProgramGoogle Scholar